» Articles » PMID: 17720519

Body Mass Index and Mortality in CKD

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2007 Aug 28
PMID 17720519
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Greater body mass index (BMI) is associated with worse survival in the general population, but appears to confer a survival advantage in patients with kidney failure treated by hemodialysis. Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD).

Study Design: Cohort study.

Setting & Participants: The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and blood pressure control on progression of kidney disease. This analysis includes 1,759 subjects.

Predictor: BMI.

Outcomes & Measurements: Cox models were used to evaluate the relationship of quartiles of BMI with all-cause and cardiovascular disease (CVD) mortality.

Results: Mean GFR and BMI were 39 +/- 21 (SD) mL/min/1.73 m(2) and 27.1 +/- 4.7 kg/m(2), respectively. During a mean follow-up of 10 years, there were 453 deaths (26%), including 272 deaths (16%) from CVD. In unadjusted Cox models, quartiles 3 (hazard ratio [HR], 1.45; 95% confidence interval [CI], 1.11 to 1.90) and 4 (HR, 1.58; 95% CI, 1.21 to 2.06) were associated with increased risk of all-cause mortality compared with quartile 1. Adjustment for demographic, CVD, and kidney disease risk factors and randomization status attenuated this relationship for quartiles 3 (HR, 0.81; 95% CI, 0.60 to 1.09) and 4 (HR, 0.83; 95% CI, 0.61 to 1.20). In unadjusted Cox models, quartiles 3 (HR, 1.66; 95% CI, 1.17 to 2.36) and 4 (HR, 1.63; 95% CI, 1.15 to 2.33) were associated with increased risk of CVD mortality. Multivariable adjustment attenuated this relationship for quartiles 3 (HR, 0.92; 95% CI, 0.63 to 1.36) and 4 (HR, 0.85; 95% CI, 0.57 to 1.27).

Limitations: Primary analyses were based on single measurement of BMI. Because the MDRD Study cohort included relatively young white subjects with predominantly nondiabetic CKD, results may not be generalizable to all patients with CKD.

Conclusions: In this cohort of subjects with predominantly nondiabetic CKD, BMI does not appear to be an independent predictor of all-cause or CVD mortality.

Citing Articles

Education programmes for people with chronic kidney disease and diabetes.

Cashmore B, Cooper T, Evangelidis N, Green S, Lopez-Vargas P, Tunnicliffe D Cochrane Database Syst Rev. 2024; 8:CD007374.

PMID: 39171639 PMC: 11339929. DOI: 10.1002/14651858.CD007374.pub3.


Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?.

Sagi B, Vas T, Csiky B, Nagy J, Kovacs T Biomedicines. 2024; 12(6).

PMID: 38927457 PMC: 11201004. DOI: 10.3390/biomedicines12061250.


Elevated Crude Mortality in Obese Chronic Kidney Disease Patients with Loss of Exercise Habit: A Cohort Study of the Japanese General Population.

Harada T, Nagai K, Mase K, Tsunoda R, Iseki K, Moriyama T Intern Med. 2022; 62(15):2171-2179.

PMID: 36543210 PMC: 10465275. DOI: 10.2169/internalmedicine.0803-22.


Impact of body mass index on in-hospital mortality in older patients hospitalized for bacterial pneumonia with non-dialysis-dependent chronic kidney disease.

Okada A, Yamaguchi S, Jo T, Yokota I, Ono S, Kurakawa K BMC Geriatr. 2022; 22(1):950.

PMID: 36494609 PMC: 9733221. DOI: 10.1186/s12877-022-03659-3.


Nutritional Predictors of Mortality after 10 Years of Follow-Up in Patients with Chronic Kidney Disease at a Multidisciplinary Unit of Advanced Chronic Kidney Disease.

Barril G, Nogueira A, Alvarez-Garcia G, Nunez A, Sanchez-Gonzalez C, Ruperto M Nutrients. 2022; 14(18).

PMID: 36145223 PMC: 9504469. DOI: 10.3390/nu14183848.